Dis-Chem director Saltzman restructures share portfolio, family ownership continues

Ivan Saltzman, a director at Dis-Chem Pharmacies, is restructuring his share portfolio held through Ivlyn Local Investment Holdings Proprietary Limited, the company announced today. The restructuring involves the distribution of 217,125,386 ordinary shares, ensuring continued family ownership. This transaction will not impact the liquidity of Dis-Chem shares traded on the JSE. The deemed value of the transaction is ZAR 6,802,538,343, based on the closing price on June 19, 2025, with the transaction dated June 20, 2025. Following the restructuring, Ivlyn's beneficial interest in Dis-Chem has decreased to 4.06%, while Dan Saltzman and Mark Saltzman now individually hold a beneficial interest of 12.62% each. The company has filed the required notice with the Takeover Regulation Panel.